These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34231077)

  • 21. ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.
    DaSilva-Arnold SC; Kuo CY; Davra V; Remache Y; Kim PCW; Fisher JP; Zamudio S; Al-Khan A; Birge RB; Illsley NP
    Mol Hum Reprod; 2019 Feb; 25(2):61-75. PubMed ID: 30462321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
    Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
    Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators.
    Rhodes LV; Tate CR; Segar HC; Burks HE; Phamduy TB; Hoang V; Elliott S; Gilliam D; Pounder FN; Anbalagan M; Chrisey DB; Rowan BG; Burow ME; Collins-Burow BM
    Breast Cancer Res Treat; 2014 Jun; 145(3):593-604. PubMed ID: 24810497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks.
    Soleymani L; Zarrabi A; Hashemi F; Hashemi F; Zabolian A; Banihashemi SM; Moghadam SS; Hushmandi K; Samarghandian S; Ashrafizadeh M; Khan H
    Curr Cancer Drug Targets; 2021; 21(9):749-767. PubMed ID: 34077345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumoral and stromal expression of Slug, ZEB1, and ZEB2 in brain metastasis.
    Nagaishi M; Nakata S; Ono Y; Hirata K; Tanaka Y; Suzuki K; Yokoo H; Hyodo A
    J Clin Neurosci; 2017 Dec; 46():124-128. PubMed ID: 28890036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible factor 3α1 increases epithelial-to-mesenchymal transition and iron uptake to drive colorectal cancer liver metastasis.
    Villareal LB; Falcon DM; Xie L; Xue X
    Br J Cancer; 2024 Jun; 130(12):1904-1915. PubMed ID: 38693428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
    Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
    Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
    Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
    Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
    Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
    Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
    Sinh ND; Endo K; Miyazawa K; Saitoh M
    Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
    Lee GA; Hwang KA; Choi KC
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer.
    Shayimu P; Yusufu A; Rehemutula A; Redati D; Jiapaer R; Tuerdi R
    Technol Cancer Res Treat; 2020; 19():1533033820967475. PubMed ID: 33084522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
    Xie R; Tang J; Zhu X; Jiang H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.